Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KONWALINKA G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tiefenthaler, M; Amberger, A; Bacher, N; Hartmann, BL; Margreiter, R; Kofler, R; Konwalinka, G
      Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells

      BRITISH JOURNAL OF HAEMATOLOGY
    2. Strasser, H; Tiefenthaler, M; Steinlechner, M; Eder, I; Bartsch, G; Konwalinka, G
      Age dependent apoptosis and loss of rhabdosphincter cells

      JOURNAL OF UROLOGY
    3. Schirmer, M; Haun, M; Grunewald, K; Geisen, F; Hilbe, W; Thaler, J; Konwalinka, G
      New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine

      ACTA HAEMATOLOGICA
    4. Zidorn, C; Stuppner, H; Tiefenthaler, M; Konwalinka, G
      Cytotoxic activities of hypocretenolides from Leontodon hispidus

      JOURNAL OF NATURAL PRODUCTS
    5. Zidorn, C; Stuppner, H; Tiefenthaler, M; Konwalinka, G
      Cytotoxic activities of hypocretenolides from Leontodon hispidus. (vol 62,pg 984, 1999)

      JOURNAL OF NATURAL PRODUCTS
    6. Schirmer, M; Geisen, F; Tiefenthaler, M; Konwalinka, G
      Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia

      LEUKEMIA RESEARCH
    7. Strasser, H; Tiefenthaler, M; Steinlechner, M; Bartsch, G; Konwalinka, G
      Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells

      LANCET
    8. Margreiter, R; Fischer, M; Roberts, K; Schmid, T; Hittmair, A; Schirmer, M; Geisen, F; Tiefenthaler, M; Konwalinka, G
      Gemcitabine - A novel immunosuppressive agent - Prevents rejection in a rat cardiac transplantation model

      TRANSPLANTATION
    9. Hilbe, W; Berger, T; Konwalinka, G; Thaler, J
      Cladribine treatment of a patient with hairy cell leukemia and concomitantmultiple sclerosis

      ACTA HAEMATOLOGICA
    10. KONWALINKA G; HOBISCH A; HEROLD M; HITTMAIR A; THUMHER M; EDER IE; CRONAUER MV; RIESER C; RAMONER R; BARTSCH G; KLOCKER H; CULIG Z
      INTERLEUKIN-1BETA IS A MEDIATOR OF EFFECTS OF MONOCYTE-CONDITIONED MEDIUM ON PROSTATE-CANCER CELLS LNCAP

      Experimental hematology
    11. SCHIRMER M; STEGMANN APA; GEISEN F; KONWALINKA G
      SENSITIVITY TO GEMCITABINE IN HL60 CELLS WITH ELEVATED 5'-NUCLEOTIDASE ACTIVITY RESISTANT TO CLADRIBINE

      Experimental hematology
    12. TIEFENTHALER M; GNAIGER E; AMBERGER A; KONWALINKA G
      LACTATE ACCUMULATION PROCEEDS EARLY APOPTOTIC LOSS IN MITOCHONDRIAL-MEMBRANE POTENTIAL

      Experimental hematology
    13. SCHIRMER M; STEGMANN APA; GEISEN F; KONWALINKA G
      LACK OF CROSS-RESISTANCE WITH GEMCITABINE AND CYTARABINE IN CLADRIBINE-RESISTANT HL60 CELLS WITH ELEVATED 5'-NUCLEOTIDASE ACTIVITY

      Experimental hematology
    14. GRAZIADEI I; KELLY T; SCHIRMER M; GEISEN FH; VOGEL W; KONWALINKA G
      ANTITUMOR EFFECT OF THE NUCLEOSIDE ANALOGS 2-CHLORODEOXYADENOSINE AND2',2'-DIFLUORODEOXYCYTIDINE ON HUMAN HEPATOMA HEPG2 CELLS

      Journal of hepatology
    15. HILBE W; APFELBECK U; FRIDRIK M; BERNHART M; NIESSNER H; ABBREDERIS K; MICHLMAYR G; PONT J; LINKESCH W; HAUSMANINGER H; ARNEITZ K; BALDINGER C; DUBA C; EISTERER W; GREIL R; KONWALINKA G; NIEDERWIESER D; GASTL G; THALER J
      INTERFERON-ALPHA FOR THE TREATMENT OF ELDERLY PATIENTS WITH CHRONIC MYELOID-LEUKEMIA

      Leukemia research
    16. SCHMID T; HECHENLEITNER P; MARK W; FISCHER M; ROBERTS K; GEISEN F; KLIMA G; DIETZE O; KONWALINKA G; MARGREITER R
      2-CHLORODEOXYADENOSINE (CLADRIBINE) IN COMBINATION WITH LOW-DOSE CYCLOSPORINE PREVENTS REJECTION AFTER ALLOGENEIC HEART AND LIVER-TRANSPLANTATION IN THE RAT

      European surgical research
    17. CULIG Z; HOBISCH A; HEROLD I; HITTMAIR A; THURNHER M; EDER IE; CRONAUER MV; RIESER C; RAMONER R; BARTSCH G; KLOCKER H; KONWALINKA G
      INTERLEUKIN-1-BETA MEDIATES THE MODULATORY EFFECTS OF MONOCYTES ON LNCAP HUMAN PROSTATE-CANCER CELLS

      British Journal of Cancer
    18. TIEFENTHALER M; GEISEN F; SCHIRMER M; KONWALINKA G
      A COMPARISON OF THE ANTIPROLIFERATIVE PROPERTIES OF RECOMBINANT HUMANIFN-ALPHA-2 AND IFN-OMEGA IN HUMAN BONE-MARROW CULTURE

      Journal of interferon & cytokine research
    19. ZELGER BG; ZELGER BWH; KONWALINKA G; MIKUZ G; FEND F
      NON-HODGKIN-LYMPHOMA WITH EXCLUSIVE INVOLVEMENT OF THE HEART AND THE GASTROINTESTINAL-TRACT

      Virchows Archiv
    20. SCHIRMER M; MUR E; PFEIFFER KP; THALER J; KONWALINKA G
      THE SAFETY PROFILE OF LOW-DOSE CLADRIBINE IN REFRACTORY RHEUMATOID-ARTHRITIS - A PILOT TRIAL

      Scandinavian journal of rheumatology
    21. THALER J; HILBE W; APFELBECK U; LINKESCH W; SILL H; SEEWANN H; PONT J; BERNHART M; STOGER M; NIESSNER H; ABBREDERIS K; GEISSLER D; HAUSMANINGER H; LIN W; LUDWIG H; LANG A; DUBA C; FLUCKINGER T; GREIL R; GRUNEWALD K; KONWALINKA G; NIEDERWIESER D; FRIDRIK M
      INTERFERON-ALPHA-2C AND LD ARA-C FOR THE TREATMENT OF PATIENTS WITH CML - RESULTS OF THE AUSTRALIAN MULTICENTER PHASE-II STUDY

      Leukemia research
    22. SCHIRMER M; HILBE W; GEISEN F; THALER J; KONWALINKA G
      T-CELLS AND NATURAL-KILLER-CELLS AFTER TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE

      Acta haematologica
    23. GRUBER J; GEISEN F; SGONC R; EGLE A; VILLUNGER A; BOECK G; KONWALINKA G; GREIL R
      2',2'-DIFLUORODEOXYCYTIDLINE (GEMCITABINE) INDUCES APOPTOSIS IN MYELOMA CELL-LINES RESISTANT TO STEROIDS AND 2-CHLORODEOXYADENOSINE (2-CDA)

      Stem cells
    24. SCHIRMER M; MICHLMAYR G; GEISEN F; KONWALINKA G
      2-CHLORODEOXYADENOSINE (2-CDA) IN CHRONIC LYMPHOCYTIC-LEUKEMIA REFRACTORY TO FLUDARABINE

      Leukemia
    25. TIEFENTHALER M; GEISEN F; SCHIRMER M; ADOLF GR; KONWALINKA G
      A COMPARISON OF THE ANTIPROLIFERATIVE PROPERTIES OF RECOMBINANT HUMANIFN-ALPHA AND IFN-OMEGA IN-VITRO IN CHRONIC MYELOIC LEUKEMIA AND NORMAL BONE-MARROW PROGENITORS

      Experimental hematology
    26. CRONAUER MV; KLOCKER H; TALASZ H; GEISEN FH; HOBISCH A; RADMAYR C; BOCK G; CULIG Z; SCHIRMER M; REISSIGL A; BARTSCH G; KONWALINKA G
      INHIBITORY EFFECTS OF THE NUCLEOSIDE ANALOG GEMCITABINE ON PROSTATIC-CARCINOMA CELLS

      The Prostate
    27. MOHSENIPOUR I; SCHIRMER M; FRANK R; GEISEN F; SEMENITZ E; ZURNEDDEN D; KONWALINKA G
      LOCAL APPLICATION OF ANTIMYCOTICS IN MUCORMYCOSIS CEREBRI - A CASE-REPORT

      Journal of Neurology, Neurosurgery and Psychiatry
    28. KONWALINKA G; SCHIRMER M; HILBE W; FEND F; GEISEN F; KNOBLECHNER A; PETZER A; THALER J
      MINIMAL RESIDUAL DISEASE IN HAIRY-CELL LEUKEMIA AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE

      Blood cells, molecules, & diseases
    29. PETZER AL; GEISEN FH; BILGERI R; ZILIAN U; HAUN M; HEROLD M; BRAUNSTEINER H; KONWALINKA G
      GROWTH-INHIBITORY EFFECT OF 2-CDA ON MYELOID CFU-GM PROGENITORS IN NORMAL HUMAN LONG-TERM BONE-MARROW CULTURES AND ITS COMPENSATION BY G-CSF OR IL-3

      Experimental hematology
    30. GRAZIADEI I; PROPST A; SCHIRMER M; KONWALINKA G; PATSCH JR; VOGEL W
      THE NUCLEOSIDE ANALOGS 2-CHLORODEOXYADENOSINE AND GEMCITABINE INHIBITGROWTH OF HUMAN HEPATOMA-CELLS IN-VITRO

      Hepatology
    31. ZABERNIGG A; HILBE W; REINISCH N; EISTERER W; THALER J; SPOTL L; KONWALINKA G
      NORMAL GRANULOCYTE FUNCTION BUT IMPAIRED MONOCYTE FUNCTION IN A PATIENT WITH APLASTIC-ANEMIA

      Acta haematologica
    32. FOGER B; ZAPF J; LECHLEITNER M; KONWALINKA G; PATSCH JR
      PREVENTION WITH GLUCOCORTICOIDS OF EXTRAPANCREATIC TUMOR-HYPOGLYCEMIAAS A RESULT OF INCREASED BIG INSULIN-LIKE GROWTH-FACTOR-II

      Journal of internal medicine
    33. SCHIRMER M; HILBE W; GEISEN F; FEND F; KNOBLECHNER A; THALER J; ZILIAN U; PETZER A; KONWALINKA G
      MONOCLONAL-ANTIBODY B-LY7 - DETECTION OF MINIMAL RESIDUAL DISEASE AFTER TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXY ADENOSINE

      Experimental hematology
    34. KONWALINKA G; SCHIRMER M; OBERHUBER G; SCHMIDT T; THALER W; KALTENBACHER A; HERBST P; GEISEN F; MARGREITER M
      2-CHLORODEOXYADENOSINE IN COMBINATION WITH CYCLOSPORINE PREVENTS REACTION AFTER ALLOGENEIC TRANSPLANTATION OF LIVER, HEART AND SMALL-BOWEL

      Experimental hematology
    35. SCHIRMER M; VOGEL W; THALER J; GRUNEWALD K; UMLAUFT F; GEISEN F; ZILIAN U; KONWALINKA G
      FULMINANT-HEPATITIS-C VIRUS-INFECTION

      Lancet
    36. SCHMID T; OBERHUBER G; THALER W; KALTENBACHER A; HERBST P; MARGREITER R; KONWALINKA G
      2-CHLORODEOXYADENOSINE IN COMBINATION WITH CYCLOSPORINE PREVENTS REJECTION AFTER ALLOGENEIC SMALL-BOWEL TRANSPLANTATION

      Transplantation proceedings
    37. OBERHUBER G; SCHMID T; THALER W; KALTENBACHER A; SCHIRMER M; LILIEMARK J; HERBST P; GEISEN F; MARGREITER R; KONWALINKA G
      EVIDENCE THAT 2-CHLORODEOXYADENOSINE IN COMBINATION WITH CYCLOSPORINEPREVENTS REJECTION AFTER ALLOGENEIC SMALL-BOWEL TRANSPLANTATION

      Transplantation
    38. LECHLEITNER M; AUER B; ZILIAN U; HOPPICHLER F; SCHIRMER M; FOGER B; GEISEN F; PATSCH JR; KONWALINKA G
      THE IMMUNOSUPPRESSIVE SUBSTANCE 2-CHLORO-2-DEOXYADENOSINE MODULATES LIPOPROTEIN METABOLISM IN A MURINE MACROPHAGE CELL-LINE (P388 CELLS)

      Lipids
    39. ROMANI N; GRUNER S; BRANG D; KAMPGEN E; LENZ A; TROCKENBACHER B; KONWALINKA G; FRITSCH PO; STEINMAN RM; SCHULER G
      PROLIFERATING DENDRITIC CELL PROGENITORS IN HUMAN BLOOD

      The Journal of experimental medicine
    40. PETZER AL; GEISEN FH; BILGERI R; ZILIAN U; HAUN M; HEROLD M; BRAUNSTEINER H; KONWALINKA G
      GROWTH-INHIBITORY EFFECT OF 2-CHLORO-2'-DEOXY ADENOSINE (CDA) ON MYELOID PROGENITORS IN NORMAL HUMAN LONG-TERM BONE-MARROW CULTURES - COMPENSATION BY INTERLEUKIN-3 AND GRANULOCYTE-COLONY-STIMULATING FACTOR

      Experimental hematology
    41. KONWALINKA G; PETZER A; GEISEN FH; SCHIRMER M; ZILIAN U; HAUN M; BRAUNSTEINER H
      A DIFFERENTIAL SENSITIVITY TO 2-CHLORODEOXYADENOSINE (2-CDA) BETWEEN NORMAL AND CHRONIC MYELOID LEUKEMIC BONE-MARROW ERYTHROID AND MYELOID PROGENITOR CELLS

      Experimental hematology
    42. SCHIRMER M; VOGEL W; THALER J; UMLAUFT F; ZILIAN U; GEISEN F; KONWALINKA G
      SUBFULMINANT HEPATITIS-C IN A PATIENT WITH HAIRY-CELL LEUKEMIA DURINGTREATMENT WITH CLADRIBINE

      Experimental hematology
    43. BILGERI R; PETZER AL; ZILIAN U; GEISEN FH; SCHIRMER M; HAUN M; KONWALINKA G
      EFFECT OF DEOXYCYTIDINE ON 2-CHLORO-DEOXYADENOSINE-MEDIATED GROWTH-INHIBITION OF NORMAL HUMAN ERYTHROID AND MYELOID PROGENITOR CELLS

      Experimental hematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/03/20 alle ore 21:34:59